Well, I'm hoping that the CEO has the integrity to relay information whatever the results might be. This company was over $.50 on air last year - no reason it couldn't shoot up there again, depending on news - good news about the trials would I think push it up to $.10 or higher in the short term and higher in the long term depending on what they do with the numbers. I would think there should be some news of some sort before the end of the month - if there isn't...I'm not thinking that way.